5-74718812-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000521.4(HEXB):​c.1258A>G​(p.Ile420Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,614,156 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I420T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0085 ( 21 hom., cov: 32)
Exomes 𝑓: 0.00090 ( 21 hom. )

Consequence

HEXB
NM_000521.4 missense

Scores

2
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.750

Publications

6 publications found
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
HEXB Gene-Disease associations (from GenCC):
  • Sandhoff disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046886504).
BP6
Variant 5-74718812-A-G is Benign according to our data. Variant chr5-74718812-A-G is described in ClinVar as Benign. ClinVar VariationId is 256355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00855 (1302/152314) while in subpopulation AFR AF = 0.0297 (1235/41568). AF 95% confidence interval is 0.0283. There are 21 homozygotes in GnomAd4. There are 616 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000521.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXB
NM_000521.4
MANE Select
c.1258A>Gp.Ile420Val
missense
Exon 11 of 14NP_000512.2P07686
HEXB
NM_001292004.2
c.583A>Gp.Ile195Val
missense
Exon 11 of 14NP_001278933.1Q5URX0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXB
ENST00000261416.12
TSL:1 MANE Select
c.1258A>Gp.Ile420Val
missense
Exon 11 of 14ENSP00000261416.7P07686
HEXB
ENST00000511181.5
TSL:1
c.583A>Gp.Ile195Val
missense
Exon 11 of 14ENSP00000426285.1Q5URX0
HEXB
ENST00000513336.5
TSL:3
c.193A>Gp.Ile65Val
missense
Exon 3 of 6ENSP00000423713.1H0Y9B6

Frequencies

GnomAD3 genomes
AF:
0.00854
AC:
1300
AN:
152196
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00218
AC:
547
AN:
251412
AF XY:
0.00165
show subpopulations
Gnomad AFR exome
AF:
0.0300
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000900
AC:
1315
AN:
1461842
Hom.:
21
Cov.:
32
AF XY:
0.000762
AC XY:
554
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0323
AC:
1083
AN:
33480
American (AMR)
AF:
0.00139
AC:
62
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000423
AC:
47
AN:
1111978
Other (OTH)
AF:
0.00172
AC:
104
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
66
133
199
266
332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00855
AC:
1302
AN:
152314
Hom.:
21
Cov.:
32
AF XY:
0.00827
AC XY:
616
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0297
AC:
1235
AN:
41568
American (AMR)
AF:
0.00333
AC:
51
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68034
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00225
Hom.:
4
Bravo
AF:
0.00932
ESP6500AA
AF:
0.0266
AC:
117
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00280
AC:
340
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Sandhoff disease (3)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
1.5
DANN
Benign
0.74
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.75
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.22
N
REVEL
Uncertain
0.33
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Vest4
0.15
MVP
0.52
MPC
0.15
ClinPred
0.00084
T
GERP RS
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.55
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77499935; hg19: chr5-74014637; API